Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
Hepatitis C virus (HCV) affects thousands of individuals in Mexico and Argentina. The launch of innovative therapies in recent years has brought new, highly effective options to the market, but reimbursement constraints tied to payers’ ability to fund these treatments sharply affect access to some of these medicines. Moreover, the type of payer—private versus public—requires companies operating in these markets to understand how the differences in economic capacity will affect their agent’s uptake. This A&R analysis provides key insights into navigating the HCV therapy market in Mexico and Argentina while adapting brand agents’ value message to payers’ and physicians’ needs and expectations in each country.
Decision Resources Group’s Access and Reimbursement module for HCV in Argentina and Mexico explores the prescribing patterns for current therapies, the potential impact of the anticipated arrival of new agents, and key national and regional market access factors that will shape the use of HCV therapies over the next two to three years. This content draws on insights from 101 surveyed physicians and from interviews with six payers in Argentina and Mexico, all of whom have influence at the regional, institutional, or national level.
Markets covered: Argentina and Mexico
Questions answered in this report:
Already a Client? Log in to access this report.
Roy manages global market access content for DRG, including US Access & Reimbursement (legacy PPF) and the Global Market Access Solution. He has 10 years of experience writing/managing in market access content, including nearly two years on the global front. For nearly five years, he has managed/directed what had been Physician & Payer Forum. Previously, he spent five years as an analyst for legacy HealthLeader-InterStudy’s health plan analysis team, focusing on Florida, Illinois, and the national Medicare market. He also had 5 years business reporting experience with a focus on healthcare.